DE69125175T2 - Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen - Google Patents
Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromenInfo
- Publication number
- DE69125175T2 DE69125175T2 DE69125175T DE69125175T DE69125175T2 DE 69125175 T2 DE69125175 T2 DE 69125175T2 DE 69125175 T DE69125175 T DE 69125175T DE 69125175 T DE69125175 T DE 69125175T DE 69125175 T2 DE69125175 T2 DE 69125175T2
- Authority
- DE
- Germany
- Prior art keywords
- atheroms
- angiotensin
- treatment
- receptor antagonists
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909027201A GB9027201D0 (en) | 1990-12-14 | 1990-12-14 | Medicaments |
PCT/GB1991/002222 WO1992010184A1 (en) | 1990-12-14 | 1991-12-12 | Use of angiotensin ii receptor antagonists in the treatment of atheroma |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69125175D1 DE69125175D1 (de) | 1997-04-17 |
DE69125175T2 true DE69125175T2 (de) | 1997-07-10 |
Family
ID=10687037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69125175T Expired - Lifetime DE69125175T2 (de) | 1990-12-14 | 1991-12-12 | Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0561876B1 (de) |
JP (1) | JPH06503336A (de) |
AU (1) | AU9064191A (de) |
DE (1) | DE69125175T2 (de) |
GB (1) | GB9027201D0 (de) |
WO (1) | WO1992010184A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP2970384A1 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonisten der guanylatcyclase und deren verwendungen |
CN113388007A (zh) | 2013-06-05 | 2021-09-14 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
EP0955294B1 (de) * | 1989-06-14 | 2003-09-24 | Smithkline Beecham Corporation | Imidazoalkensäure |
CA2018443A1 (en) * | 1989-06-14 | 1990-12-14 | Joseph A. Finkelstein | Imidazolyl-alkenoic acids |
-
1990
- 1990-12-14 GB GB909027201A patent/GB9027201D0/en active Pending
-
1991
- 1991-12-12 AU AU90641/91A patent/AU9064191A/en not_active Abandoned
- 1991-12-12 JP JP4501729A patent/JPH06503336A/ja active Pending
- 1991-12-12 DE DE69125175T patent/DE69125175T2/de not_active Expired - Lifetime
- 1991-12-12 WO PCT/GB1991/002222 patent/WO1992010184A1/en active IP Right Grant
- 1991-12-12 EP EP92900436A patent/EP0561876B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH06503336A (ja) | 1994-04-14 |
GB9027201D0 (en) | 1991-02-06 |
EP0561876A1 (de) | 1993-09-29 |
EP0561876B1 (de) | 1997-03-12 |
DE69125175D1 (de) | 1997-04-17 |
AU9064191A (en) | 1992-07-08 |
WO1992010184A1 (en) | 1992-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE110556T1 (de) | Verbesserungen bei der behandlung von zähnen. | |
NO932005D0 (no) | Angiotensin-ii-antagonister | |
DE69332898T2 (de) | 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten | |
DE69941566D1 (de) | N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie | |
DE69128941D1 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung der diabetischen nephropathie | |
NO911749L (no) | Bis-arylamid og urea-antagonister for blodplateaktiverende faktor. | |
MX9101311A (es) | Antagonistas receptores de fibrinogeno | |
ATE286510T1 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
MX9100717A (es) | Antagonistas de la bradiquinina | |
DE69829763D1 (de) | Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii | |
DE69418203D1 (de) | Zementiermittel und ihre verwendung | |
DE69432595D1 (de) | Antagonisten des angiotensin ii-rezeptors zur behandlung von chronischen entzündlichen erkrankungen | |
DE69133390D1 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorragischem schlaganfall | |
DE69214283T2 (de) | Verwendung von cellulase bei der zellstoffbehandlung | |
DE69125175T2 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen | |
DE69534632T2 (de) | Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit | |
DE69524623T2 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
DE69132782D1 (de) | Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie | |
NO930262L (no) | Bombesin-antagonister | |
EE9400365A (et) | Inimese gamma- interferooni antagonistid | |
FI930108A0 (fi) | Imidazopyridin-paf-antagonister | |
DE69424779D1 (de) | Verwendung von triazinverbindungen bei angstzuständen | |
DE69302250D1 (de) | Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia | |
DE69819503D1 (de) | Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose | |
ATE25846T1 (de) | Pseudotropylhalogenbenzoate und ihre verwendung bei der behandlung von migraene. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |